Document Migration

PRODUCTS

  • PHCbi brand’s 25.6 cu.ft (725L) FrostLess ultra-low temperature freezer provides reliable temperatures as low as -86°C. It is engineered to mitigate frost buildup more than our category-leading models while maintaining the reliability and energy efficiency that today's laboratories require. It operates on 115V and uses only 7.9kWh per day. ENERGY STAR® Certified.

  • Navigating the complex landscape of scientific and regulatory affairs is a challenge for biotech companies. That's why our team is committed to providing solutions tailored to meet these unique needs.

  • AES has transformed the landscape of modular cleanroom design, manufacturing and construction. What began as a vision to elevate industry standards has evolved into a legacy of cleanroom solutions that protect the world’s most critical processes.

  • Accelerate your biomanufacturing capacity with purpose-built modules

    KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.

  • Chemocatalyzed steps in synthetic routes are known to afford high selectivities, yields and atom economy. A chemocatalytic reaction optimization requires large number of experiments to identify a suitable catalyst, catalyst loading, solvent, temperature, pressure etc. The chemocatalysis team at Aragen Life Sciences has the capabilities to optimize processes using high throughput screening combined with DoE from gram to multikilo scale with ready access to catalysts and ligands.

WHITE PAPERS AND CASE STUDIES

NEWS